Tuesday, september 21, 2021 tagFinancial results

Date of approval of the final consolidated financial statements for the year ending June 2021

  • SHARE ON
  • twitter
  • facebook
  • linkedin

It is now expected that the final consolidated financial statements for the year ended June 2021 will be approved by the Board of Directors at its meeting on October 20, 2021.

Ramsay Santé
In its press release of August 25, 2021 relating to the publication of the provisional annual results at the end of June 2021, Ramsay Santé indicated that the final consolidated financial statements for the year ended June 2021 would be approved by the Board of Directors at its meeting on September 23, 2021.

As the finalization of these financial statements and their review by the auditors will require additional time, it is now expected that the final consolidated financial statements for the year ended June 2021 will be approved by the Board of Directors at its meeting on October 20, 2021.

ISIN code and Euronext Paris: FR0000044471
Website: www.ramsaygsante.eu


Investor Relations/Analysts
Marcus Nord
Tél. +46 733 97 72 57
marcus.nord@capio.com

Press Relations
Brigitte Cachon
Tél. +33 6 12 29 56 52
b.cachon@ramsaygds.fr

About Ramsay Santé

Ramsay Santé is the leader in private hospitalisation and primary care in Europe. The Group has 36,000 employees and works with nearly 9,300 practitioners to treat more than 10 million patients per year in its 443 facilities and 5 countries: France, Sweden, Norway, Denmark and Italy. Ramsay Santé offers almost all medical and surgical specialities in three domains: Medicine, Surgery, Obstetrics (MSO), Follow-up Care and Rehabilitation (FCR) and Mental Health.

Legally, Ramsay Santé is a mission-oriented company committed to constantly improving the health of all patients through innovation. Wherever it operates, the Group contributes to public health service missions and the healthcare network. Through its actions and the constant dedication of its teams, Ramsay Santé is committed to ensuring the entire patient care journey, from prevention to follow-up care.

Every year, the group invests over 200 million euros in innovation to support the evolution and diversity of care pathways, in medical, hospital, digital, and administrative aspects. Through this commitment, our Group enhances access to care for all, commits to provides best-in-class healthcare, systematically engages in dialogue with stakeholders and strives to protect the planet to improve health.

Tuesday, september 21, 2021 tagFinancial results
  • SHARE ON
  • twitter
  • facebook
  • linkedin
Downloads
Contact
  • Brigitte Cachon
  • Director of Communication, Brand & CSR
  • +33 (0)1 87 86 22 11
Related News
View all releases